MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

MMJ Recs

JUNE 17, 2024

When dealing with chronic pain, finding relief can be a daily struggle for many people. Traditional pain medications often come with a slew of side effects and may not even provide adequate relief. Medicinal marijuana offers a natural and effective way to manage pain, with fewer adverse effects than traditional medications.

Strains 52

Strains Chronic Pain Indica Sativa 52

Cannabis Law Report

DECEMBER 1, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, today announced that it will participate in two investor conferences during the month of December 2021. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Chronic Pain Therapy 52

CannaTech

JANUARY 16, 2019

Pharmaceutical grade cannabis is relatively new in parts of the world. This statistic accounts for medicines treating patients with epilepsy, anxiety, depression, chronic pain, and other illnesses. Legal access does not necessarily equate to financial access. million people.

Access 89

Access Patients Pharmaceutical Education 89

SpeedWeed

APRIL 9, 2021

Eighty percent of all respondents said they were using weed to help with chronic pain, and 52 percent of veteran respondents said they used it for PTSD. . The post 61% of Medical Cannabis Users in Texas Said Weed Helped Them Get off Pharmaceuticals appeared first on SpeedWeed. View original article.

Pharmaceutical 52

Pharmaceutical Chronic Pain Programs Patients 52

MMJ Recs

AUGUST 1, 2024

While antiretroviral therapy (ART) has transformed HIV/AIDS from a fatal diagnosis to a manageable chronic condition, patients often endure chronic pain, nausea, appetite loss, and psychological distress. As such, patients report reduced reliance on opioids and other pain medications, which often come with severe side effects.

Patients 52

Patients Chronic Pain Marijuana Sleep 52

LifeCannMD

AUGUST 30, 2024

Florida’s legalization of medical marijuana in 2016 marked a significant shift in how patients manage chronic conditions. Coconut Grove has embraced this change, with residents increasingly turning to medical cannabis as a natural alternative to traditional pharmaceuticals.

Marijuana 52

Marijuana Chronic Pain Treatment Pharmaceutical 52

MGC Pharma

FEBRUARY 22, 2018

An increasing number of older people are seeking the treatment for conditions such as inflammatory arthritis, autoimmune disease and chronic pain. Unfortunately, the regulatory process is fraught with bottlenecks, with no more than 500 Australians having legal access to Medical Cannabis. namely Australia’s aging population.

Research and Development 100

Research and Development Pharmaceutical Chronic Pain Treatment 100

Veriheal

MAY 31, 2022

opioid epidemic, which claimed a record number of lives in 2021 , is the result of America’s faulty regulation of these powerful pain-killing drugs and a widespread lack of access to safe and adequate pain management solutions. For too long, America has relied too heavily on opioids for pain relief. The Opioid Problem.

Programs 52

Programs Chronic Pain Treatment Conditions 52

Cannabis Law Report

JANUARY 5, 2022

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced that the U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Treatment 52

Cannabis Law Report

NOVEMBER 23, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced that the U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Chronic Pain 52

Cannabis Law Report

NOVEMBER 16, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced today that it has received U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

MedicalJane

OCTOBER 28, 2022

Millions of Americans, especially older individuals, are turning to medical marijuana for managing their chronic pain symptoms. This increasing number of states that have legalized medical marijuana makes it easier for patients to obtain a prescription from their doctor, making it more accessible than ever before.

Chronic Pain 86

Chronic Pain Marijuana Medicine Pharmaceutical 86

LifeCannMD

NOVEMBER 24, 2023

Medical marijuana may be recommended for conditions such as chronic pain, epilepsy, multiple sclerosis, Crohn’s disease, cancer, and other qualifying conditions. Medical marijuana is known for its potential to alleviate symptoms like pain, nausea, muscle spasms, and seizures.

Marijuana 52

Marijuana Chronic Pain Conditions Patients 52

Veriheal

APRIL 21, 2022

It is a great day indeed especially for patients suffering from chronic pain—like medical cannabis advocate Pearl Schomburg—who can finally access this excellent alternative to other risky pharmaceutical treatments. .

Chronic Pain 97

Chronic Pain Pharmaceutical Medicine Patients 97

MMJ Recs

APRIL 1, 2024

From its anti-inflammatory properties to its ability to alleviate pain, CBD shows promise in addressing various health conditions. Studies have suggested that CBD may help manage chronic pain, reduce anxiety and depression, alleviate symptoms of epilepsy, and even aid in cancer treatment.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Canna Care Docs

DECEMBER 11, 2018

However, with medical cannabis continuing to spread through the country—and with more and more research pointing to its benefits for everything from chronic pain and sleep problems to anxiety and arthritis—the tide seems to be turning. Numerous studies point to that fact, especially in cases surrounding chronic pain and discomfort.

Chronic Pain 76

Chronic Pain Sleep Clinical Trials Medicine 76

The Cannigma

JUNE 25, 2022

Patients must have a doctor’s prescription as well as permission from a regional pharmaceutical inspector to obtain cannabis products. Qualifying conditions include chronic pain, multiple sclerosis, spasticity, chemo-induced nausea, and treatment-resistant epilepsy. These products are typically more accessible in larger cities.

Legalization 112

Legalization Supply Chain Chronic Pain Tincture 112

Cannabis Law Report

APRIL 1, 2022

CELADON Pharmaceuticals successfully listed on the Alternative Investments Market (AIM) this week, making it the first British company to join in 21 years. It also owns a majority stake in LVL Health , a chronic pain clinic, alongside a minority stake in cannabinoid-based biopharmaceutical company Kingdom Therapeutics.

Chronic Pain 52

Chronic Pain Pharmaceutical Sativa Business 52

PrestoDoctor

OCTOBER 13, 2023

Marinol, also known as Dronabinol, is a medication used to treat a variety of conditions, including nausea and vomiting caused by chemotherapy, loss of appetite and weight loss in people with HIV/AIDS, as well as chronic pain. However, unlike marijuana, Marinol is a FDA-approved pharmaceutical drug.

THC 98

THC Chronic Pain Treatment Conditions 98

Cannabis Law Report

JUNE 28, 2021

Cannabis products are fast becoming available that could deliver significant improvements to the lives of thousands of patients suffering from conditions ranging from chronic pain to post traumatic stress disorder. Kanabo is an established leader in medical cannabis research and innovation. Kanabo Group Plc. Michelle Tamir.

Research and Development 105

Research and Development Chronic Pain Medicine Policy 105

Veriheal

AUGUST 9, 2023

CBD, Trema micrantha, and the Study’s Significance CBD means cannabidiol , one of over a hundred compounds in the cannabis plant, and is widely celebrated as a potential treatment for a long list of health concerns, including chronic pain , epilepsy , i nsomnia , anxiety , and skin allergy.

CBD 96

CBD Cannabinoids THC Extraction 96

Cannabis Law Report

JULY 20, 2021

With our new psychedelic medicinal insurance solutions, business can access the necessary coverages to protect their business, attract qualified officers/directors, and bring new treatments to market.”. Rahn & Associates announced today that it launched new risk management solutions for the burgeoning psychedelic medicinal industry.

Medicine 98

Medicine Business Research and Development Chronic Pain 98

MMJ Recs

FEBRUARY 18, 2024

These may include chronic pain, nausea and vomiting related to chemotherapy, muscle spasms, seizures, and mental health disorders. One of the most well-known applications is pain relief, particularly for chronic pain, arthritis, and neuropathic pain.

Chronic Pain 52

Chronic Pain Marijuana Epilepsy Research and Development 52

Cannabis Law Report

JUNE 7, 2019

The farm is run by GW Pharmaceuticals, where around two million cannabis plants have been produced since its opening in 1998. Those suffering from epilepsy, nausea and chronic pain due to chemotherapy are now given the option to get the drug on prescription, reports The Mirror . Something has finally happened in Sittingbourne.

Chronic Pain 40

Chronic Pain Epilepsy Legalization Pharmaceutical 40

Veriheal

AUGUST 13, 2020

THC is primarily responsible for the psychoactive effects users feel, and it also helps to combat nausea, increase appetite, encourage sleep, and relieve chronic pain. EPM-301 takes its name from the company EPM, a startup dedicated to bridging the gap between organic cannabis and the needs of pharmaceutical companies.

Cannabinoids 98

Cannabinoids Chronic Pain Sleep Pharmaceutical 98

MMJ Recs

FEBRUARY 3, 2024

Pennsylvania Medical Cannabis Program and Philadelphia Marijuana Dispensaries The Pennsylvania Medical Cannabis Program serves as the foundation for medical marijuana accessibility in Philadelphia. This can lead to a decreased reliance on pharmaceuticals that may adversely affect patients’ health and overall lifestyle.

Legislation 52

Legislation Law Marijuana Dispensary 52

Cannabis Law Report

NOVEMBER 23, 2021

The products to be manufactured at the facility aren’t specified, but will be used for managing chronic pain, epilepsy, multiple sclerosis, and pain associated with palliative care. The subject land is zoned RU1 Primary Production. Further information on the proposed project can be found here.

Chronic Pain 52

Chronic Pain Epilepsy Environment Pharmaceutical 52

Canna Law Blog

MARCH 4, 2020

People are increasingly using ketamine for ailments that resist treatment through traditional pharmaceutical drugs. However, it is also being used for off-label infusions for the management of psychiatric disorders and chronic pain management (enter the clinics).

Therapy 93

Therapy Legalization Chronic Pain DEA 93

Veriheal

MAY 17, 2021

Other states have gone beyond just medical access and have also legalized retail cannabis markets for adult consumers. Please don’t further the lie by voting for any form of legalization beyond the pharmaceutical remedies already available under state law.” ” State Doctors Oppose Legalization in Alabama.

Legalization 93

Legalization Pharmaceutical Therapy Chronic Pain 93

Veriheal

NOVEMBER 10, 2020

The experiment will allow participating companies to import cannabis and the companies who wish to participate in the experiment will be obliged to give participants free medical cannabis which has to comply with the pharmaceutical standards and good manufacturing practice. .

Chronic Pain 87

Chronic Pain Pharmaceutical Patients Epilepsy 87

Cannabis Law Report

MAY 28, 2019

Veterans Struggle to Gain Access to Medical Marijuana. Despite this expansion military veterans often face greater obstacles to gaining access to medical marijuana than other groups. Other common health problems include tinnitus, hearing loss, and lower-back pain. What is the VA’s Position of Medical Marijuana?

Access 49

Access Marijuana Research and Development Programs 49

Weedistry

DECEMBER 29, 2018

Most of the wave of incoming leaders after our recent midterm elections, at the state and federal level, support expanding access to medical marijuana. I previously worked as an emergency room doctor and have witnessed firsthand how helpful this drug can be for patients struggling with chronic pain and a myriad of symptoms.

Chronic Pain 45

Chronic Pain Pharmaceutical Treatment Patients 45

Veriheal

JUNE 20, 2022

The FDA has also approved a few cannabis-based pharmaceutical drugs. Cannabis legalization is already showing that places with legal access to cannabis are seeing a drop in dependency on pharmaceutical prescriptions. Cannabis is helping patients fight cancer, control seizure disorders, fight chronic pain, and so much more.

Chronic Pain 97

Chronic Pain Advocacy Pharmaceutical Legalization 97

MMJ Recs

MAY 15, 2022

But in the years since 2017, lawmakers have steadily improved Virginia’s medical marijuana program and made it accessible to a wider range of people. Medical marijuana products are produced and sold in Virginia by businesses called “pharmaceutical processors”. Recently, Virginia legalization has changed in several ways.

Patients 52

Patients Marijuana Pharmaceutical Dispensary 52

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

MMJ Recs

JANUARY 22, 2024

CBD edibles, ranging from gummies to infused snacks, provide a discreet and precisely dosed method for individuals seeking relief from conditions such as anxiety, chronic pain, and insomnia. Meanwhile, THC-dominant edibles can be instrumental in alleviating symptoms associated with chronic pain and enhancing overall well-being.

Edibles 52

Edibles Marijuana Chronic Pain THC 52